MBB Public Markets’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-611
Closed -$304K 533
2025
Q1
$304K Buy
+611
New +$331K 0.03% 417
2024
Q4
Sell
-540
Closed -$334K 503
2024
Q3
$334K Sell
540
-28,738
-98% -$17M 0.02% 280
2024
Q2
$16.2M Buy
29,278
+25,901
+767% +$14.8M 0.33% 61
2024
Q1
$1.96M Sell
3,377
-14,053
-81% -$7.89M 0.12% 76
2023
Q4
$9.25M Buy
17,430
+2,974
+21% +$1.44M 0.57% 37
2023
Q3
$7.32M Buy
14,456
+700
+5% +$373K 0.44% 46
2023
Q2
$7.18M Buy
13,756
+9,045
+192% +$4.88M 0.38% 51
2023
Q1
$2.72M Buy
+4,711
New +$2.66M 0.15% 52
2022
Q1
Sell
-2,827
Closed -$1.89M 422
2021
Q4
$1.89M Buy
+2,827
New +$1.77M 0.04% 70

Other funds holding TMO

MBB Public Markets's TMO Position: Q2 2025 in Review

MBB Public Markets sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 611 shares — an estimated $304K sold.

MBB Public Markets first reported a position in TMO in Q4 2021 and held it in 9 quarters. The position peaked at $16.2M in Q2 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • MBB Public Markets reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • MBB Public Markets sold 611 Thermo Fisher Scientific shares in Q2 2025, an estimated $304K.
  • MBB Public Markets first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 9 quarters.
  • MBB Public Markets's Thermo Fisher Scientific position peaked at $16.2M in Q2 2024.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on MBB Public Markets's 13F filing for Q2 2025, filed 14 Aug 2025.